Page Title
Clinical Trial Finder
Ask About Participating in This Study
Nutritional-GIEnrolling
Study to evaluate ANG003 in people with CF ages 12 and older, protocol number Anagram ANG003-25-201The following information will be used to determine eligibility for this study. Fill out the form and click “Preview Message.” This will draft an email you can send directly to the Research Coordinator. Please note, this does not guarantee entry into this particular study.
* indicates required field
Personal Information
Add more details about who you are and how you would like to be contacted (e.g. phone, text, email).
(this will open in your email program)
Nutritional-GIEnrolling
Study to evaluate ANG003 in people with CF ages 12 and older, protocol number Anagram ANG003-25-201
This study will assess the safety and effectiveness of ANG003, a pancreatic enzyme replacement therapy (also known as “enzymes” or “enzyme therapy”) to see whether it works as well as the approved enzyme therapy Creon.
-
Age:
12 Years and Older
-
Mutation(s):
No Mutation Requirement
-
FEV1% Predicted:
30% or greater
-
Number of Visits:
6
-
Length of Participation:
3 months
Related Topics
CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Check the Drug Development Pipeline
We’re attacking CF from every angle. Learn about the status of CF drugs in development.
Learn More